SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer ...Middle East

SEOUL, South Korea, May 9, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial....

Hence then, the article about sn bioscience receives fda fast track designation for small cell lung cancer was published today ( Friday 10/05/2024 - 07:13 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer )

Also on site :

• Nigerian general killed in Islamic State attack
• Finn Wolfhard Told ‘Malcolm in the Middle’ Creator “F*ck Yeah” To Revival Cameo: “He’s Such A Big Fan”
• Best-Selling Author's Novel Consistently Ranks Among Top Reader Favorites on Goodreads